2-(butylthio)-N,9-bis(2,6-difluoro-3-methylbenzyl)-9H-purin-6-amine | 1133753-38-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 2-(butylthio)-N,9-bis(2,6-difluoro-3-methylbenzyl)-9H-purin-6-amine
• 英文别名: 2-butylsulfanyl-N,9-bis[(2,6-difluoro-3-methylphenyl)methyl]purin-6-amine
• CAS: 1133753-38-4
• 化学式: C₂₅H₂₅F₄N₅S
• 分子量: 503.567
• InChiKey: SSFDFYMZYLVLGK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.7
• 重原子数：
  35
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  80.9
• 氢给体数：
  1
• 氢受体数：
  9

文献信息

• [EN] NEW PYRIMIDINE DERIVATIVES FOR PREVENTION AND TREATMENT OF GRAM-NEGATIVE BACTERIAL INFECTION, CONTAMINATION AND FOULING<br/>[FR] NOUVEAUX DÉRIVÉS DE PYRIMIDINE POUR LA PRÉVENTION ET LE TRAITEMENT D'UNE INFECTION, D'UNE CONTAMINATION ET DE SALISSURES PAR UNE BACTÉRIE À GRAM NÉGATIF
  申请人：UNIV LIEGE

  公开号：WO2020212553A1

  公开（公告）日：2020-10-22

  New pyrimidine derivatives together with a membrane penetrating agent, optionally with a detectable isotope and pharmaceutical composition for use in treatment or prevention of Gram-negative bacterial infection in a host mammal in need of such treatment or prevention and use as inhibitors of Gram-negative biofilm formation on a surface of biomaterial or medical device, particularly of cardiovascular device such as prosthetic heart valve or pacemakers. New pyrimidine derivatives together with a membrane penetrating agent; for use as radiotracer in diagnosing or prognosing Gram-negative bacterial infection in a host mammal.

  新的嘧啶衍生物与膜穿透剂一起，可选地带有可检测同位素和药物组合物，用于治疗或预防宿主哺乳动物体内需要此类治疗或预防的革兰氏阴性细菌感染，并用作抑制生物材料或医疗器械表面上的革兰氏阴性生物膜形成的抑制剂，特别是心血管器械，如假体心脏瓣膜或起搏器。新的嘧啶衍生物与膜穿透剂一起；用作放射示踪剂，用于诊断或预测宿主哺乳动物体内的革兰氏阴性细菌感染。
• [EN] DERIVATIVES OF ADENINE AND 8-AZA-ADENINE AND USES THEREOF-796<br/>[FR] DÉRIVÉS DE L'ADÉNINE ET DE LA 8-AZA-ADÉNINE ET LEURS UTILISATIONS
  申请人：ASTRAZENECA AB

  公开号：WO2009034386A1

  公开（公告）日：2009-03-19

  The invention relates to chemical compounds, or pharmaceutically acceptable salts thereof of the formula (I): which have bacterial MurI inhibitory activity and are accordingly useful for their treatment and prophylaxis of bacterial infection, e.g., E.faecalis or E. faeciuminfection. Further, the invention relates to methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of the compounds, to pharmaceutical compositions containing them, and to their use in the manufacture of medicaments of use in the treatment and prevention of various bacterial diseases in a warm-blooded animalsuch as man.

  该发明涉及化合物或其药用可接受的盐，其化学式为（I）：具有细菌MurI抑制活性，因此可用于治疗和预防细菌感染，例如E.faecalis或E. faecium感染。此外，该发明涉及人体或动物体的治疗方法。该发明还涉及化合物的制造方法，含有这些化合物的药物组合物，以及它们在制造用于治疗和预防人类等恒温动物各种细菌疾病的药物中的应用。
• NEW PYRIMIDINE DERIVATIVES FOR PREVENTION AND TREATMENT OF GRAM-NEGATIVE BACTERIAL INFECTION, CONTAMINATION AND FOULING
  申请人：Université de Liège

  公开号：EP3955929A1

  公开（公告）日：2022-02-23
• PYRIMIDINE DERIVATIVES FOR PREVENTION AND TREATMENT OF GRAM-NEGATIVE BACTERIAL INFECTION, CONTAMINATION AND FOULING
  申请人：UNIVERSITÉ DE LIÈGE

  公开号：US20210290625A1

  公开（公告）日：2021-09-23

  New pyrimidine derivatives together with a membrane penetrating agent, optionally with a detectable isotope and pharmaceutical composition for use in treatment or prevention of Gram-negative bacterial infection in a host mammal in need of such treatment or prevention and use as inhibitors of Gram-negative biofilm formation on a surface of biomaterial or medical device, particularly of cardiovascular device such as prosthetic heart valve or pacemakers. New pyrimidine derivatives together with a membrane penetrating agent; for use as radiotracer in diagnosing or prognosing Gram-negative bacterial infection in a host mammal.